Raise closed, search for fresh raises on Seedstage

Solana Beach, CA

Commercializing ultra-high definition wearable monitors designed to improve surgeon ergonomics and visualization in microsurgery and robotic procedures.

• Innovative product launch: CR3 Wearable Surgical Monitor introduced in partnership with Carl Zeiss Meditec.
• Market opportunity: Positioned within a $10-15 billion emerging surgical visualization market.
• Experienced leadership: Founders with decades of medtech innovation and commercialization expertise.
• Exclusive technology licensing: Partnership with Kopin Corporation for advanced display technology.
• Ergonomic focus: Designed to reduce surgeon fatigue and improve situational awareness during procedures.

HMDmd is raising funds to support the commercialization and further development of its ultra-high definition wearable surgical monitors designed for microsurgery, robotic, and minimally invasive procedures. The offering aims to accelerate production and expand partnerships within the growing surgical visualization market, addressing ergonomic challenges faced by surgeons with traditional displays. Funds will also be used to enhance product features, support distribution channels, and develop next-generation wearable display technologies.

The company’s flagship product, the CR3 Wearable Surgical Monitor, launched in April 2025 in partnership with Carl Zeiss Meditec, a global leader in surgical microscopes. HMDmd holds exclusive technology licenses and is positioned to access a significant emerging market estimated at $10-15 billion. The team’s strong experience in medical device innovation, combined with strategic industry relationships and a growing clinical advisory board, supports the company’s growth and potential for broad adoption of its ergonomic visualization solutions.

Company Info

HMDmd designs advanced wearable surgical monitors that enhance surgeon visualization and ergonomics for minimally invasive procedures.

HMDmd develops ultra-high definition wearable surgical monitors designed to improve visualization and ergonomics for surgeons performing microsurgery, robotic-assisted, minimally invasive, and interventional procedures. Their flagship product, the CR3 Wearable Surgical Monitor, offers natural 3D visualization with true depth perception, preserving peripheral vision and situational awareness through an open-display design. This reduces surgeon fatigue and the risk of musculoskeletal injuries associated with traditional surgical monitors and microscopes. The device features a lightweight 260g design and a LookDown feature allowing seamless transitions between surgical displays and direct patient views.

HMDmd operates within an emerging $10-15 billion global market for wearable surgical visualization, partnering with leading industry players like Carl Zeiss Meditec and Kopin Corporation. The company holds exclusive technology licenses and distribution agreements, targeting integration with surgical system manufacturers via an OEM distribution model. Their strategic clinical advisory board and early adoption by surgeons position HMDmd to set new industry benchmarks in surgical visualization. The company aims to address a critical need for ergonomic, real-time, and immersive surgical displays to enhance precision and safety in operating rooms worldwide.